Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG). (Record no. 17698465)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02048 a2200529 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515103827.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200902s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1573-7217 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s10549-008-9894-7 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kahán, Zsuzsanna |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20090203 |
245 00 - TITLE STATEMENT | |
Title | Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Breast cancer research and treatment |
Date of publication, distribution, etc. | Dec 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 557-63 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chemotherapy, Adjuvant |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclophosphamide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epirubicin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Filgrastim |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Granulocyte Colony-Stimulating Factor |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Medical Oncology |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polyethylene Glycols |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Spanik, Stanislav |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wagnerova, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Skacel, Tomas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Planko, Barbara |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fitzthum, Elisabeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lindner, Elisabeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Soldatenkova, Victoria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zielinski, Christoph C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brodowicz, Thomas |
773 0# - HOST ITEM ENTRY | |
Title | Breast cancer research and treatment |
Related parts | vol. 112 |
-- | no. 3 |
-- | p. 557-63 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10549-008-9894-7">https://doi.org/10.1007/s10549-008-9894-7</a> |
Public note | Available from publisher's website |
No items available.